Page 2 - Panacea Biotec
Panacea Biotec surges 15% on launch of Prasugrel drug in US market
The stock surged 15% to Rs 276, also its 52-week high on the BSE
 "Panacea Biotec surges 15% on launch of Prasugrel drug in US market")
Updated On : 24 Oct 2017 | 2:14 PM IST
Panacea Biotec zooms 18% on USFDA approval for migraine drug
The stock surged 18% to Rs 149, also its 52-week high on the NSE in noon deal on back of heavy volumes.
 "Panacea Biotec zooms 18% on USFDA approval for migraine drug")
Updated On : 18 Jan 2017 | 1:15 PM IST
Panacea Biotec gains on launch of Tetravalent Vaccine Easyfour-TT
The stock surged 10% to Rs 127 on the BSE in intra-day trade in otherwise weak market
 "Panacea Biotec gains on launch of Tetravalent Vaccine Easyfour-TT")
Updated On : 26 Dec 2016 | 12:33 PM IST
Panacea Biotec gains on EIR from USFDA for Baddi unit
The EIR is for the Baddi unit at Himachal Pradesh for Oncology Parenteral and Oral Solids Dosage formulation facilities
 "Panacea Biotec gains on EIR from USFDA for Baddi unit")
Updated On : 21 Nov 2016 | 11:17 AM IST
